Rosemonde Mandeville
Chairman at Biophage, Inc.
Profile
Rosemonde Mandeville is currently the Chairman at Biophage, Inc., the Director at Armand-Frappier Foundation, and the Director at Cancer Research Society.
Previously, Dr. Mandeville held positions such as Chairman, President & Chief Executive Officer at Biophage Pharma, Inc. in 2009, and Director at Montec Holdings, Inc. and Phagelux (Canada), Inc. Dr. Mandeville obtained a doctorate degree from the University of Manitoba and an undergraduate degree from Alexandria University.
Rosemonde Mandeville active positions
Companies | Position | Start |
---|---|---|
Armand-Frappier Foundation | Director/Board Member | 2011-10-11 |
Cancer Research Society
Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Director/Board Member | 2011-10-11 |
Biophage, Inc.
Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Chairman | - |
Former positions of Rosemonde Mandeville
Companies | Position | End |
---|---|---|
Montec Holdings, Inc. | Director/Board Member | 2009-02-04 |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Director/Board Member | - |
Biophage Pharma, Inc.
Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Chief Executive Officer | - |
Training of Rosemonde Mandeville
University of Manitoba | Doctorate Degree |
Alexandria University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Biophage Pharma, Inc.
Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | Health Technology |
Montec Holdings, Inc. | Technology Services |
Armand-Frappier Foundation | |
Cancer Research Society
Cancer Research Society Miscellaneous Commercial ServicesCommercial Services The Cancer Research Society is a non-profit organization that focuses on cancer research. The organization is based in Montreal, Canada. The organization has received support from Stéphane Rousseau, who is a spokesperson for the organization and actively supports their efforts. Max Fehlmann has been the CEO of the Canadian company since 2017. | Commercial Services |
Biophage, Inc.
Biophage, Inc. Pharmaceuticals: MajorHealth Technology Biophage, Inc. develops pharmaceutical products. The company is headquartered in Montreal, Canada. | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Phagelux (Canada), Inc. specializes in biological products except diagnostic substances. The firm offers its products for solving bacterial problems in agricultural, food safety, animal health, and topical and inhaled treatments to treat various diseases. The company was incorporated on March 11, 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Rosemonde Mandeville